WW International, Inc. (WW)
| Market Cap | 127.88M |
| Revenue (ttm) | 692.33M -9.6% |
| Net Income | 1.08B |
| EPS | 107.70 |
| Shares Out | 10.00M |
| PE Ratio | 0.12 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 631,147 |
| Open | 11.32 |
| Previous Close | 10.09 |
| Day's Range | 11.22 - 13.15 |
| 52-Week Range | 8.37 - 46.95 |
| Beta | 1.06 |
| Analysts | Buy |
| Price Target | 28.33 (+121.5%) |
| Earnings Date | May 7, 2026 |
About WW
WW International, Inc. provides weight management products and services in the United States, Germany, Canada, and internationally. It offers various nutritional, activity, behavioral, and lifestyle tools and approaches for individual weight goals, as well as for people taking GLP-1 medications or living with diabetes, as well as offers guidance and medication access for women reaching perimenopause and menopause. The company also provides Core, a digital subscription product for weight loss and weight management; Core+ tier, a subscription for... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for WW stock is "Buy." The 12-month stock price target is $28.33, which is an increase of 121.50% from the latest price.
News
WW International Proxy statement: Proxy filing
WW International filed a proxy statement on May 15, 2026, providing details for shareholder voting and corporate governance matters.
Galloway Capital announces 8.42% stake in WW
Galloway Capital Partners announced that it has accumulated an ownership stake of approximately 8.42% in WW (WW) International. Galloway believes WW “is materially undervalued despite owning one of th...
WW up 5% to $10.13 after Galloway Capital announces stake
Galloway called WW (WW) shares “materially undervalued” in a press release on its stake.
Galloway Capital Partners Announces Investment in WW International and Believes Shares Are Worth Multiples of Current Price
NEW YORK--(BUSINESS WIRE)--Galloway Capital Partners, LLC (“Galloway”), together with its affiliates, today announced that it has accumulated an ownership stake of approximately 8.42% in WW Internatio...
WW International Q1 Earnings Call Highlights
WW International NASDAQ: WW, operator of WeightWatchers, reaffirmed its 2026 financial outlook after reporting first-quarter results that reflected continued pressure in its legacy behavioral subscrip...
WW price target lowered to $20 from $21 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on WW (WW) to $20 from $21 and keeps an Equal Weight rating on the shares.
WW International Earnings Call Transcript: Q1 2026
Q1 2026 saw strong growth in clinical and Core+ segments, with clinical revenue up 32% and Core+ subscribers up 6% year-over-year. Revenue declined 10% overall, but ARPU rose 13% and gross margin remained near record highs. 2026 guidance for revenue and adjusted EBITDA was reaffirmed.
WW International Earnings release: Q1 2026
WW International released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
WW International Quarterly report: Q1 2026
WW International has published its Q1 2026 quarterly earnings report on May 7, 2026.
WW International Shareholder letter: Q1 2026
WW International has published a letter to shareholders covering Q1 2026, which was released on May 7, 2026.
WW International Logs Lower Sales
WW International posted lower revenue in the first quarter, as behavioral subscription sales fell.
Weight Watchers Announces First Quarter 2026 Results
Total End of Period Subscribers of 2.7 million; End of Period Clinical Subscribers of 197 thousand, up 46% year-over-year Revenue of $168 million; Clinical Subscription Revenue of $39 million, up 32% ...
Weight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide)
The addition of Ozempic® pill will give Weight Watchers Med+ members a new FDA-approved oral GLP-1 option for adults living with type 2 diabetes The addition of Ozempic® pill will give Weight Watchers...
WW International Proxy statement: Proxy filing
WW International filed a proxy statement on April 30, 2026, providing details for shareholder voting and corporate governance matters.
WW reaffirms Q1 subscriber estimates, FY26 financial guidance
WW (WW) International announced that it intends to utilize up to $40M in cash to prepay and reduce the principal amount of its outstanding term loan. In connection with today’s…
WW jumps 21% after paying down debt, backing FY26 guidance
Shares of WW (WW) International, the parent of Weight Watchers, are up $2.04, or 22%, to $11.31 in early trading.
Weight Watchers Announces Actions to Utilize Up to $40 million to Pay Down Debt
NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced that it in...
Weight Watchers Schedules First Quarter 2026 Earnings Conference Call
NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”) will release its results for the first quarter 2026 ended March 31, 2026, before m...
WW appoints Thiltgen to the company’s Board of Directors
WW (WW) International announced that it has appointed Heather Thiltgen to the Company’s Board of Directors, effective April 20, 2026. Thiltgen currently serves as the President of Presbyterian Health ...
Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced that it ha...
Weight Watchers Announces Board Committee Appointments
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced the follow...
Weight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors
New, Independent Directors Bring Deep Consumer, Digital and Turnaround Expertise to Support Strategic Transformation New, Independent Directors Bring Deep Consumer, Digital and Turnaround Expertise to...
WW announces establishment of Office of the CEO, Transition Committee
WW (WW) International announced leadership and governance changes, including the establishment of an Office of the CEO and the formation of a new Transition Committee of the Board of Directors.
Weight Watchers Announces Leadership Transition and Board Updates
Office of the CEO Established to Oversee Business Operations Board Forms Transition Committee and Commences CEO Search NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW)...
WW price target lowered to $21 from $34.50 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on WW (WW) to $21 from $34.50 and keeps an Equal Weight rating on the shares. A mix shift from behavioral to clinic…